The protection efficiency of the neutralizing antibody nCoV617 in the ACE2-HU mouse model postinfection with SARS-CoV-2 (a Chinese endemic strain). (A) The scheme flowchart of the experiment. (B to D) In the ACE2 humanized mouse model, body weight (B) and virus copies of SARS-CoV-2 in lung (C) and in trachea (D) count in the therapeutic, prophylactic, and irrelevant MAb (Ag005) negative-control groups. (E to G) Hematoxylin-eosin (HE) staining of ACE2-HU mouse lung tissue sections of the negative-control (E), prophylactic (F), and therapeutic (G) groups. Results presented in panels B to D are representatives of three independent biological experiments.